Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Carlsson

Showing results (461-470 of 492) with videos related to

Pageof 50
Sort By:
Journal of Clinical Medicine|January 23, 2020
Pregnancy Associated Plasma Protein-A as a Cardiovascular Risk Marker in Patients with Stable Coronary Heart Disease During 10 Years Follow-Up-A CLARICOR Trial Sub-StudyErik Nilsson, Jens Kastrup, Ahmad Sajadieh, et al.
Journal of the American College of Cardiology|August 26, 2017
Efficacy of Rosuvastatin in Children With Homozygous Familial Hypercholesterolemia and Association With Underlying Genetic MutationsEvan A Stein, Eldad J Dann, Albert Wiegman, et al.
Family Practice|February 1, 2018
Barriers and facilitators among health professionals in primary care to prevention of cardiometabolic diseases: A systematic reviewPer E Wändell, Anne-Karien M de Waard, Martin J Holzmann, et al.
International Journal of Environmental Research and Public Health|December 9, 2020
High Variability in Implementation of Selective-Prevention Services for Cardiometabolic Diseases in Five European Primary Care SettingsChristos Lionis, Marilena Anastasaki, Antonios Bertsias, et al.
The Journal of Allergy and Clinical Immunology|August 21, 2018
Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen-specific T-cell reactivityCaroline B K Mathiesen, Michael C Carlsson, Stephanie Brand, et al.
The European Journal of General Practice|August 15, 2019
What should selective cardiometabolic prevention programmes in European primary care look like? A consensus-based design by the SPIMEU groupNorbert Král, Anne-Karien M de Waard, François G Schellevis, et al.
Age and Ageing|July 24, 2022
The relevance of geriatric assessments on the association between chronic kidney disease stages and mortality among older people: a secondary analysis of a multicentre cohort studyAndrea Corsonello, Luca Soraci, Johan Ärnlöv, et al.
Diabetologia|May 26, 2018
Multiplex proteomics for prediction of major cardiovascular events in type 2 diabetesChristoph Nowak, Axel C Carlsson, Carl Johan Östgren, et al.
Journal of Clinical Medicine|January 25, 2020
Clinical Implications of Estimating Glomerular Filtration Rate with Three Different Equations Among Older People. Preliminary Results of the Project "Screening for Chronic Kidney Disease among Older People across Europe (SCOPE)"Andrea Corsonello, Regina Roller-Wirnsberger, Gerhard Wirnsberger, et al.
BMC Geriatrics|October 3, 2020
Chronic kidney disease in the context of multimorbidity patterns: the role of physical performance : The screening for CKD among older people across Europe (SCOPE) studyAndrea Corsonello, Paolo Fabbietti, Francesc Formiga, et al.
Pageof 50

Showing results (461-470 of 492) with videos related to

Sort By:
Pageof 50
Journal of Clinical Medicine|January 23, 2020
Pregnancy Associated Plasma Protein-A as a Cardiovascular Risk Marker in Patients with Stable Coronary Heart Disease During 10 Years Follow-Up-A CLARICOR Trial Sub-StudyErik Nilsson, Jens Kastrup, Ahmad Sajadieh, et al.
Journal of the American College of Cardiology|August 26, 2017
Efficacy of Rosuvastatin in Children With Homozygous Familial Hypercholesterolemia and Association With Underlying Genetic MutationsEvan A Stein, Eldad J Dann, Albert Wiegman, et al.
Family Practice|February 1, 2018
Barriers and facilitators among health professionals in primary care to prevention of cardiometabolic diseases: A systematic reviewPer E Wändell, Anne-Karien M de Waard, Martin J Holzmann, et al.
International Journal of Environmental Research and Public Health|December 9, 2020
High Variability in Implementation of Selective-Prevention Services for Cardiometabolic Diseases in Five European Primary Care SettingsChristos Lionis, Marilena Anastasaki, Antonios Bertsias, et al.
The Journal of Allergy and Clinical Immunology|August 21, 2018
Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen-specific T-cell reactivityCaroline B K Mathiesen, Michael C Carlsson, Stephanie Brand, et al.
The European Journal of General Practice|August 15, 2019
What should selective cardiometabolic prevention programmes in European primary care look like? A consensus-based design by the SPIMEU groupNorbert Král, Anne-Karien M de Waard, François G Schellevis, et al.
Age and Ageing|July 24, 2022
The relevance of geriatric assessments on the association between chronic kidney disease stages and mortality among older people: a secondary analysis of a multicentre cohort studyAndrea Corsonello, Luca Soraci, Johan Ärnlöv, et al.
Diabetologia|May 26, 2018
Multiplex proteomics for prediction of major cardiovascular events in type 2 diabetesChristoph Nowak, Axel C Carlsson, Carl Johan Östgren, et al.
Journal of Clinical Medicine|January 25, 2020
Clinical Implications of Estimating Glomerular Filtration Rate with Three Different Equations Among Older People. Preliminary Results of the Project "Screening for Chronic Kidney Disease among Older People across Europe (SCOPE)"Andrea Corsonello, Regina Roller-Wirnsberger, Gerhard Wirnsberger, et al.
BMC Geriatrics|October 3, 2020
Chronic kidney disease in the context of multimorbidity patterns: the role of physical performance : The screening for CKD among older people across Europe (SCOPE) studyAndrea Corsonello, Paolo Fabbietti, Francesc Formiga, et al.
Pageof 50